AWM
ICPT

Accurate Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Accurate Wealth Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35
Closed -$542 – 1567
2022
Q4 		$542 Buy
+35
New +$496 ﹤0.01% 1471

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Accurate Wealth Management's ICPT Position: Q1 2023 in Review

Accurate Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 35 shares — an estimated $542 sold.

Accurate Wealth Management first reported a position in ICPT in Q4 2022 and held it in 1 quarter. The position peaked at $542 in Q4 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

  • Accurate Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Accurate Wealth Management sold 35 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $542.
  • Accurate Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Accurate Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $542 in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.